Alexandra Harrington, MD, MT (ASCP)

Publications

• Hemophagocytosis in cerebrospinal fluid after CAR T-cell therapy.

  (Shah NN, Harrington AM.) Blood. 2022 Feb 17;139(7):1116 PMID: 35175320 SCOPUS ID: 2-s2.0-85124777621 02/18/2022

• Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome.

  (Corrao K, Rezwan S, Atallah E, Michaelis LC, Runaas L, Harrington AM, Abedin S.) Leuk Res Rep. 2022;17:100329 PMID: 35651540 PMCID: PMC9150024 SCOPUS ID: 2-s2.0-85131561638 06/03/2022

• Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse.

  (Dhakal B, Sharma S, Balcioglu M, Shchegrova S, Malhotra M, Zimmermann B, Billings PR, Harrington A, Sethi H, Aleshin A, Hari PN.) Front Oncol. 2022;12:786451 PMID: 35186734 PMCID: PMC8848740 SCOPUS ID: 2-s2.0-85124893548 02/22/2022

• Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient.

  (Cardwell LA, Majerowski J, Chiu YE, Harrington AM, Sokumbi O.) J Cutan Pathol. 2021 May;48(5):706-712 PMID: 33476057 SCOPUS ID: 2-s2.0-85102302501 01/22/2021

• Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia.

  (Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS.) Leuk Lymphoma. 2021 Jan;62(1):158-166 PMID: 32951486 SCOPUS ID: 2-s2.0-85091139710 09/22/2020

• Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them.

  (Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN.) Biol Blood Marrow Transplant. 2020 Jul;26(7):1288-1297 PMID: 32135202 SCOPUS ID: 2-s2.0-85083636589 03/07/2020

• Simple Laboratory Test Utilization Interventions to Reduce Inappropriate Specialty Coagulation Testing.

  (Huang H, Cunningham AM, Harrington AM.) Am J Clin Pathol. 2020 Jan 02;153(2):181-189 PMID: 31602457 SCOPUS ID: 2-s2.0-85077403173 10/12/2019

• Ancillary Studies in the Diagnostic Evaluation of Large B-Cell Lymphoma.

  (Cunningham AM, Harrington AM.) Arch Pathol Lab Med. 2019 Dec;143(12):1464-1471 PMID: 31584842 SCOPUS ID: 2-s2.0-85075813941 10/05/2019

• Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review.

  (Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM.) Int J Lab Hematol. 2019 Feb;41(1):69-79 PMID: 30216684 SCOPUS ID: 2-s2.0-85053471510 09/15/2018

• Daratumumab in Primary Effusion Lymphoma.

  (Shah NN, Singavi AK, Harrington A.) N Engl J Med. 2018 Aug 16;379(7):689-690 PMID: 30110586 SCOPUS ID: 2-s2.0-85051817119 08/16/2018

• Flow Cytometry of B-Cell Neoplasms.

  (Kroft SH, Harrington AM.) Clin Lab Med. 2017 Dec;37(4):697-723 PMID: 29128065 SCOPUS ID: 2-s2.0-85028626763 11/13/2017

• CD30 Expression in Monomorphic Posttransplant Lymphoproliferative Disorder, Diffuse Large B-Cell Lymphoma Correlates With Greater Regulatory T-Cell Infiltration.

  (Hartley C, Vaughan JW, Jarzembowski J, Kroft SH, Hosking P, Harrington AM, Olteanu H.) Am J Clin Pathol. 2017 Nov 20;148(6):485-493 PMID: 29126177 SCOPUS ID: 2-s2.0-85038129680 11/11/2017